Glenmark Pharmaceuticals Enters Exclusive Agreement with Cyndea Pharma S.L. for Generic Soft-Gelatin Capsule Drug Products
Newsroom
Glenmark receives ANDA approval for Amlodipine and Olmesartan Medoxomil Tablets
8 Jul 2017 | Read More
Glenmark Pharmaceuticals receives MHRA Approval for Maloff Protect as Pharmacy license in the UK
4 Jul 2017 | Read More
Glenmark receives ANDA approval for Indomethacin Extended-Release Capsules USP-75mg
29 Jun 2017 | Read More
Glenmark Pharmaceuticals Receives Tentative ANDA Approval For Solifenacin Succinate Tablets, 5 mg and 10 mg
22 Jun 2017 | Read More
Glenmark Pharmaceuticals Licenses Small Molecule Oncology Compound from APC Therapeutics to Expand Immuno-Oncology Portfolio
21 Jun 2017 | Read More
Tentative ANDA approval for Saxagliptin Tablets, 2.5 mg and 5 mg
14 Jun 2017 | Read More
ANDA approval for Atomoxetine Capsules USP, 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg
31 May 2017 | Read More
ANDA approval for Nebivolol Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg
29 May 2017 | Read More
ANDA approval for Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg
26 May 2017 | Read More
Glenmark Pharmaceuticals to Initiate Clinical Study for GBR 1342
16 May 2017 | Read More
Glenmark's consolidated revenue increased by 6.52% to Rs. 24,571.83 Mn for Q4 FY 2016 -- 17
11 May 2017 | Read More
Glenmark Pharmaceuticals Initiates Clinical Investigation for GBR 310, its Proposed Biosimilar Candidate for XOLAIR®
25 Apr 2017 | Read More
Glenmark Pharmaceuticals receives tentative ANDA approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg and 150 mg
19 Apr 2017 | Read More
Glenmark Pharmaceuticals receives ANDA approval for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg
10 Apr 2017 | Read More
Glenmark Pharmaceuticals receives tentative ANDA approval for Milnacipran Hydrochloride Tablets, 12.5 mg, 25 mg, 50 mg and 100 mg
31 Mar 2017 | Read More
Glenmark Pharmaceuticals reports positive results from a Phase 3 trial of GSP 301
30 Mar 2017 | Read More
Glenmark Pharmaceuticals receives tentative ANDA approval for Fingolimod Capsules, 0.5 Mg
20 Mar 2017 | Read More
Glenmark Pharmaceuticals Receives FDA Clearance of IND for GSP 304
8 Mar 2017 | Read More
Glenmark Pharmaceuticals and Evestra, Inc. Announce Partnership Agreement for Generic NuvaRing®
2 Mar 2017 | Read More
Glenmark’s consolidated revenue increases by 42.55 % to Rs. 25,350.08 Mn for Q3 FY 2016 – 17
2 Feb 2017 | Read More
Glenmark Pharmaceuticals Receives FDA Clearance of IND for GBR 1302-BEAT™ Phase I Trial
3 Jan 2017 | Read More
Library
Profile – Chairman and Managing Director
With the idea of creating something unique, Glenn Saldanha took over the reins of the company and helped transform it into a global enterprise worth USD 1.1 billion with offices across 20 countries. Download Profile
Profile – Glenmark Pharmaceuticals
Research-driven, global and integrated pharmaceutical company which is driven to meet unmet medical needs and help pave a new way for a new world. Download Profile
For any media related queries, please email corpcomm@glenmarkpharma.com